RxDoctor Payments Data

Dennis Collins, MD

Gastroenterology · Gainesville, FLNPI 1205870110

Payments from drug & device makers

$779in general payments, 2019–2025

Across 22 payments — averaging $35.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$277
  • Olympus America Inc.$142
  • Boston Scientific$142
  • Nestle Healthcare Nutrition Inc.$86
  • Medtronic$46
  • Regeneron Healthcare Solutions, Inc.$33
  • plus $53 from 5 others

What the payments were for

  • Food & beverage$779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$779 in reported general payments places this provider in the 20th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida

Medicare billing

Part B allowed, 2024
$159,218
Medicare patients
572
Services billed
2,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide20$16,568
MovantikNaloxegol Oxalate13$5,168
Omeprazole278$3,743
SutabSod Sulf/Pot Chloride/Mag Sulf13$2,090
Budesonide DrBudesonide17$1,606
Pantoprazole Sodium82$1,121
Cholestyramine LightCholestyramine12$1,041
Esomeprazole Magnesium21$635
Lansoprazole17$593
Famotidine14$460
Dicyclomine Hcl22$443
Bethanechol Chloride11$359
Sucralfate15$257
Amitriptyline Hcl11$249
Lactulose19$237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$11$16,56820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →